Ella J. Ariza-Heredia, MD
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2001 | Pontificia Universidad Javeriana, Bogota, CO, Medicine, Physician and Surgeon |
Postgraduate Training
| 2023-2023 | Quality Training Program, American Society of Clinical Oncology, Alexandria, Virginia |
| 2013-2013 | Clinical Safety & Effectiveness Training Program, Session 19, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2010-2011 | Clinical Fellowship, Transplant Infectious Diseases, Mayo Clinic, Rochester, Rochester, Minnesota |
| 2010-2010 | Infection Control Fellows Course, Infectious Diseases, Infectious Diseases Society of America and Society for Health Care and Epidemiology of America, Arlington, Virginia |
| 2008-2010 | Clinical Fellowship, Infectious Diseases, University of Miami, Miami, Florida |
| 2006-2008 | Clinical Residency, Internal Medicine, Cleveland Clinic Florida, Weston, Florida |
| 2005-2006 | Clinical Internship, Internal Medicine, Cleveland Clinic Florida, Weston, Florida |
Licenses & Certifications
| 2011 | Texas Medical License |
| 2010 | American Board of Internal Medicine, Infectious Diseases |
| 2009 | Florida Board of Medicine |
| 2008 | American Board of Internal Medicine |
| 2003 | Ministry of Health, Colombia |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Infectious Diseases, Baylor College of Medicine, Houston, TX, 2017 - 2023
Associate Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023
Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017
Administrative Appointments/Responsibilities
Physician Consultant, Pharmacy Vaccine Clinic Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2025 - Present
Clinical Director of Hematopoietic Stem Cell Transplant-Related Infections, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present
Other Professional Positions
Steering Committee for Stem Cell Transplantation and Cellular Therapy, Infectious Diseases and Collaborators, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Steering Committee of the Transplant Infectious Diseases Special Interest Group, American Society for Blood and Marrow Transplantation (ASBMT), Arlington Heights, IL, 2015 - 2019
Consultant Physician, Theravance, Inc, Houston, TX, 2013
Intramural Institutional Committee Activities
Member, Credentials Committee of the Medical Staff (CCMS), The University of Texas MD Anderson Cancer Center, 2022 - 2025
Member, Infectious Diseases Chair Advisory Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2023
Member, Vice Provost Population Science Advisory Council (VP-PSAC), The University of Texas MD Anderson Cancer Center, 2017 - 2018
Member, The MD Anderson Chimeric Antigen Receptor Therapy Toxicity (CARTOX) Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present
Member, Clinical Effectiveness Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2022
Member, Transfusion Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2019
Member, Infection Control, Main and Core Group, The University of Texas MD Anderson Cancer Center, 2011 - 2016
Honors & Awards
| 2024 | Ambulatory Celebrate Improvement, Honorable Mention, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2024 | Education and Mentorship Advancement, Faculty Excellence Awards, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2024 | Division of Internal Medicine Excellence Award in Quality, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2023 | James S. and Suzanne Cyrus Scholar Award in Clinical Research Finalist, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2018 | Division of Internal Medicine Excellence Award Nominee in Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2018 | Fellow, Infectious Diseases Society of America, Arlington, VA |
| 2017 | Multi-Year Appointment Award, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2014 | Fellow, American College of Physicians, Philadelphia, PA |
| 2014 | James S. and Suzanne Cyrus Scholar Award in Clinical Research Winner, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2010 | Outstanding Fellow Award, Infectious Diseases Fellowship, University of Miami, Jackson Memorial Hospital, Miami, FL |
| 2009 - 2010 | Infectious Diseases Society of America Travel Grant, Infectious Diseases Society of America, Arlington, VA |
| 2007 | Circle of Honor, Women's Professional Staff Association, Cleveland Clinic, Weston, FL |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. Improving Vaccination Rates in the General Internal Medicine Clinic. Invited. General Internal Medicine Clinical and Research Conference. Houston, Texas, US.
- 2023. Improving Vaccinations in Patients with Cancer. Invited. Internal Medicine and Cancer Survivorship Grand Rounds. Houston, TX, US.
- 2023. Updates on Immunization Recommendations with Focus on Immunocompromised Patients. Invited. General Internal Medicine Clinical and Research Conference. Houston, TX, US.
- 2023. Assessment of Retained Immunity and Antibody Response to Vaccine Preventable Infections in Patients Undergoing Immune Effector Cell Therapy. Conference. Cyrus Award Presentation - The 2023 Division of Internal Medicine Research Retreat. Houston, TX, US.
- 2022. Gram-Negative Antimicrobial Coverage De-Escalation in Neutropenic Fever. Invited. Stem Cell Transplantation Departmental Meeting. Houston, TX, US.
- 2021. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcus Vaccines in Survivors of CART-T or TCR Therapy. Invited. Survivorship Research Grand Rounds. Houston, TX, US.
- 2021. Immunizations in Patients with Cancer and Survivors: An Evidence Based and Practical Approach. Invited. LEAP-N Monthly Learning Series. Houston, TX, US.
- 2019. Vaccination in Cancer Patients. Invited. Physician Assistant Continuing Education (PACE) Lecture Series. Houston, TX, US.
- 2017. Updates on Immunizations after Hematopoietic Stem Cell Transplantation. Invited. Transplant Infectious Diseases Group Meeting. Houston, TX, US.
- 2015. Improving Vaccination Compliance after Stem Cell Transplant. Invited. Internal Medicine & Cancer Survivorship Grand Rounds. Houston, TX, US.
- 2015. What Cancer Patients and Survivors Need to Know About Vaccinations. Invited. Survivorship Conference. Houston, TX, US.
- 2015. Human Papillomavirus Infection in Solid Organ and Stem Cell Transplant Recipients. Invited. Abdominal Transplant Center Conference. Houston, TX, US.
- 2015. Vaccinations in Cancer Survivors. Invited. Medical Issues in Cancer Patients and Survivors. Houston, TX, US.
- 2014. Influenza Vaccination in Leukemia Patients. Invited. Leukemia Departmental Meeting. Houston, TX, US.
- 2013. Immunizations in Cancer Patients: A Practical Approach. Invited. Internal Medicine Departmental Research Meeting. Houston, TX, US.
- 2013. Quality Improvement Project to Improve Compliance in Vaccination in Stem Cell Transplant Patients. Conference. Clinical Safety and Effectiveness Training Program. Houston, TX, US.
- 2013. Guidelines for Vaccination after Stem Cell Transplantation. Invited. Stem Cell Transplantation Departmental Meeting. Houston, TX, US.
- 2013. Vaccinations in the Cancer Patient. Invited. General Internal Medicine Monthly Nursing Lecture. Houston, TX, US.
National Presentations
- 2022. Histoplasmosis, Blastomycosis, Coccidioidomycosis and the Immunocompromised Host - Risk Assessment. Invited. The 2022 ID Week. Washington, DC, US.
- 2022. Putting Quality Into Practice. Invited. The 2022 ID Week. Washington, DC, US.
- 2021. Immunizations in Stem Cell Transplant Recipients: An Evidence Based Approach to Everyday Questions. Invited. Moffitt Cancer Center. Tampa, FL, US.
- 2019. Antimicrobial Stewardship in Stem Cell Transplant Patients. Invited. The 2019 ID Week. Washington, DC, US.
- 2017. Emerging Challenges in Vaccinations in HSCT. Invited. American Society of Microbiology. New Orleans, LA, US.
- 2013. Vaccination Guidelines after Stem Cell Transplantation: Practitioner's Knowledge and Attitudes, and the Gap between Guidelines and Clinical Practice. Conference. The 2013 ID Week. San Francisco, CA, US.
International Presentations
- 2021. How to Best Manage Pneumonia in Transplant Patients. Invited. The 31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
- 2019. Outcomes of Influenza Infection in Vaccinated and Non-Vaccinated Patients with Cancer. Conference. The 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Amsterdam, NL.
- 2017. A Prospective Observational Study to Evaluate a Cytomegalovirus (CMV)-Specific Enzyme-Linked Immunospot (Elispot) Assay in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients: The REACT Study. Conference. The 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Vienna, AT.
- 2016. Evaluation of Long-Term Immunity to Varicella, Measles, Mumps, Rubella in Hematopoietic Stem Cell Transplant Survivors. Conference. The 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Amsterdam, NL.
- 2015. Vaccines after Hematopoietic Stem Cell Transplant. Invited. Instituto Nacional de Cancerologia de Mexico. Cancun, MX.
Grant & Contract Support
| Date: | 2025 - Present |
| Title: | Improving Adult Immunization Rates for COVID-19, Influenza, and Routine Adult Vaccinations through Partnerships with Medical Subspecialty Professional Societies |
| Funding Source: | SoftDev Incorporated |
| Role: | PI |
| ID: | RCTS: 00065378 |
| Date: | 2022 - Present |
| Title: | Correlation of the Microbiome and Virome in Respiratory Specimens of Recipients of Immune Effector Cellular Therapies with Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines |
| Funding Source: | Infectious Diseases Research Award |
| Role: | PI |
| ID: | PA12-0627 |
| Date: | 2022 - 2025 |
| Title: | Improving Adult Immunization Rates for COVID-19, Influenza, and Routine Adult Vaccinations through Partnerships with Medical Subspecialty Professionals |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | PI |
| ID: | 1 NH23IP922656-01-00 |
| Date: | 2019 - Present |
| Title: | Evaluation of Immunity and Response to Tetanus-Diphtheria-Pertussis Vaccine after Chimeric Antigen Receptor (CART) Cell Therapy |
| Funding Source: | Cancer Survivorship Research Seed Money Grants |
| Role: | PI |
| ID: | PA12-0627 |
| Date: | 2019 - 2022 |
| Title: | A Phase 3 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety And Efficacy Of Letermovir (LET) Prophylaxis When Extended From 100 Days To 200 Days Post-Transplant In Cytomegalovirus (CMV) Seropositive Recipients (R+) Of An Allogenic Hematopoietic Stem Cell Transplant (HSCT) |
| Funding Source: | Merck Sharp & Dohme Corp |
| Role: | PI |
| ID: | RCTS #CS2019-00057087 |
| Date: | 2017 - 2020 |
| Title: | Phase II Randomized, Placebo-controlled, Multicenter Trial to Evaluate Protective Function of CMV-MVA Triplex Vaccine in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant |
| Funding Source: | City of Hope National Med Center |
| Role: | Co-PI |
| ID: | RCTS #CS2017-00053615-HM |
| Date: | 2015 - 2020 |
| Title: | A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMW Reactivation Events - Assessed by a CMV-specific T-SPOT Assay: The REACT Study |
| Funding Source: | Oxford Immunotec |
| Role: | PI |
| ID: | PA15-0305 |
| Date: | 2015 - 2017 |
| Title: | Immune Monitoring of Hematopoietic Stem Cell Transplant Recipients at Risk for Cytomegalovirus Reactivation |
| Funding Source: | Oxford Immunotec |
| Role: | PI |
| ID: | PA13-0520 |
Selected Publications
Peer-Reviewed Articles
- Ashley, PA, Strati, P, Taherian, M, Mulanovich, VE, Ariza Heredia, EJ. Whipple's disease in a patient with follicular lymphoma. Diagnostic Microbiology and Infectious Disease 112(2), 2025. e-Pub 2025. PMID: 40043335.
- Sanft T, Day AT, Ansbaugh SM, Ariza-Heredia EJ, Armenian S, Baker KS, Ballinger TJ, Cathcart-Rake EJ, Cohen SH, Evgeniou E, Fairman NP, Feliciano J, Flores TF, Friedman DL, Gabel NM, Goldman ME, Hill-Kayser CE, Hock K, Kline-Quiroz C, Koura D, Lee NK, McDonough AL, Mooney K, Moore HCF, Moryl N, Neuman H, Overholser L, Patel CG, Peterson LL, Pirl WF, Porpiglia A, Rogers LQ, Saidain A, Schapira L, Smith SK, Tenne L, Tevaarwerk A, Ah DV, Yang EH, Zee P, McMillian N, Freedman-Cass D. NCCN Guidelines Insights: Survivorship, Version 2.2025. J Natl Compr Canc Netw 23(6):208-217, 2025. e-Pub 2025. PMID: 40499584.
- Shafat, T, De-La-Rosa-Martinez, D, Khawaja, F, Jiang, Y, Spallone, A, Batista, MV, Ariza-Heredia, EJ, Vilar-Compte, D, Ahmed, S, Becnel, M, Chemaly, RF. Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma. Open Forum Infectious Diseases 12(4), 2025. e-Pub 2025. PMID: 40177586.
- Batista, MV, Sassine, J, Khawaja, F, Kulkarni, PA, Angelidakis, G, Kmeid, J, El Chaer, F, Ariza-Heredia, EJ, Graviss, EA, Mulanovich, VE, Chemaly, RF. The Utility of Interferon-γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer. Transplant Infectious Disease 27(2), 2025. e-Pub 2025. PMID: 39731624.
- Daher, M, Khawaja, F, Spallone, A, Shigle, TL, Bhatti, MM, Vuong, NN, Ariza-Heredia, EJ, Mulanovich, VE, Champlin, RE, Chemaly, RF. Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients. Transplant Infectious Disease 27(2), 2025. e-Pub 2025. PMID: 39826146.
- Angelidakis G, Chemaly RF, Sahasrabhojane PV, Morado-Aramburo O, Jiang Y, Bhatti MM, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Elhajj P, Wargo JA, Jenq RR, Ajami NJ, Kebriaei P, Ariza-Heredia EJ. Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study. Vaccines (Basel) 12(9), 2024. e-Pub 2024. PMID: 39340100.
- Khawaja, F, Ahmed, S, Iyer, S, Sassine, J, Handley, G, Prakash, R, Vanwierren, T, Jackson, J, Zubovskaia, A, Ramdial, JL, Rondon, G, Patel, K, Spallone, A, Ariza Heredia EJ, Mulanovich, VE, Angelidakis, G, Jiang, Y, Chemaly, RF. Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy. Open Forum Infectious Diseases 11(8), 2024. e-Pub 2024. PMID: 39086466.
- Febres-Aldana, A, Khawaja, F, Morado-Aramburo, O, Shigle, TL, Rondon, G, Sassine, J, Spallone, A, Srinivasan, K, Ramdial, JL, Alousi, AM, Champlin, RE, Chen, GL, Daher, M, Rezvani, K, Ariza Heredia EJ, Shpall, E, Chemaly, RF. Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis. Clinical Microbiology and Infection 30(6):803-809, 2024. e-Pub 2024. PMID: 38460821.
- Khawaja, F, Angelidakis, G, Feldman, A, Ravi, V, Woodman, E, Bhatti, MM, Ariza Heredia EJ, Elhajj, P, Spallone, A, Jiang, Y, Chemaly, RF. COVID-19 in cancer patients. Cancer medicine 12(24):22006-22022, 2023. e-Pub 2023. PMID: 38063366.
- Ariza-Heredia EJ, Winston DJ, Rowley SD, Mullane K, Chandrasekar P, Hari P, Avery RK, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad SB, El Haddad L, Shah DP, Jiang Y, Khawaja F, Dadwal S, Blanchard T, Chemaly RF. Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant. Open Forum Infect Dis 10(8):ofad386, 2023. e-Pub 2023. PMID: 37636519.
- Khawaja F, Srinivasan K, Spallone A, Feldman A, Cantu S, Ariza-Heredia EJ, Dvordak T, Alousi A, Ahmed S, George M, Frenzel E, Bhatti M, Chemaly RF. Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: lessons learned. Am J Infect Control 51(5):506-513, 2023. e-Pub 2023. PMID: 35901993.
- Spallone A, Ariza-Heredia EJ, Chemaly RF. Acute and Latent Viral Infections in Immunocompromised Patients: A Tale of Brave Battles and Menacing Foes. Clin Microbiol Infect 28(10):1319-1320, 2022. e-Pub 2022. PMID: 35724870.
- Angelidakis G, Khawaja F, Mulanovich VE, Dailey-Garnes N, Ariza-Heredia EJ, Chemaly RF. Combination of baloxavir and oseltamivir for treatment of severe influenza infection in hematopoietic cell transplant recipients: a novel treatment strategy for a high-risk population. Microbes Infect 24(3):104895, 2022. e-Pub 2022. PMID: 34756990.
- Sassine J, Khawaja F, Shigle TL, Handy V, Foolad F, Aitken SL, Jiang Y, Champlin R, Shpall E, Rezvani K, Ariza-Heredia EJ, Chemaly RF. Refractory and resistant cytomegalovirus after hematopoietic cell transplant in the letermovir primary prophylaxis era. Clin Infect Dis 73(8):1346-1354, 2021. e-Pub 2021. PMID: 33830182.
- Strati P, Varma A, Adkins S, Nastoupil LJ, Westin J, Hagemeister FB, Fowler NH, Lee HJ, Fayad LE, Samaniego F, Ahmed S, Chen Y, Horowitz S, Arafat S, Johncy S, Kebriaei P, Mulanovich VE, Ariza-Heredia EJ, Neelapu SS. Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma. Haematologica 106(10):2667-2672, 2021. e-Pub 2021. PMID: 32732355.
- Ariza-Heredia EJ, Frenzel E, Cantu S, Carlson M, Thomas G, Khawaja F, Raad II, Chemaly RF. Surveillance and identification of clusters of health care workers with COVID-19: Multidimensional interventions at a comprehensive cancer center. Infect Control Hosp Epidemiol 42(7):1-21, 2021. e-Pub 2021. PMID: 33183368.
- Chemaly RF, El Haddad L, Winston DJ, Rowley SD, Mulane KM, Chandrasekar P, Avery RK, Hari P, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad SB, Dadwal SS, Blanchard T, Shah DP, Jiang Y, Ariza-Heredia EJ. Cytomegalovirus (CMV) cell-mediated immunity and CMV infection after allogeneic hematopoietic stem cell transplantation: The REACT study. Clin Infect Dis 71(9):2365-2374, 2020. e-Pub 2020. PMID: 32076709.
- Aldoss I, La Rosa C, Baden LR, Longmate J, Ariza-Heredia EJ, Rida WN, Lingaraju CR, Zhou Q, Martinez J, Kaltcheva T, Dagis A, Hardwick N, Issa NC, Farol L, Nademanee A, Al Malki MM, Forman S, Nakamura R, Diamond DJ, Study Group TV. Poxvirus vectored cytomegalovirus vaccine to prevent cytomegalovirus viremia in transplant recipients: A phase 2, randomized clinical trial. Ann Intern Med 172(5):306-316, 2020. e-Pub 2020. PMID: 32040960.
- Kmeid J, Kulkarni PA, Batista MV, El Chaer F, Prayag A, Ariza-Heredia EJ, Mulanovich VE, Chemaly RF. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014. BMC Infect Dis 19(1):934, 2019. e-Pub 2019. PMID: 31694567.
- Figgins B, Hammerstrom A, Ariza-Heredia EJ, Oran B, Milton DR, Yeh J. Characterization of viral Infections after antithymocyte globulin-based conditioning in adults undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 25(9):1837-1843, 2019. e-Pub 2019. PMID: 31128324.
- Doan VP, Yeh JC, Gulbis AM, Aitken SL, Ariza-Heredia EJ, Ahmed S. Levofloxacin versus cefpodoxime for antibacterial prophylaxis in allogeneic stem cell transplantation. Biol Blood Marrow Transplant 25(8):1637-1641, 2019. e-Pub 2019. PMID: 31002991.
- Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF. Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic stem cell transplantation recipients. Clin Infect Dis, 2019. e-Pub 2019. PMID: 30202920.
- El Haddad L, Ariza-Heredia EJ, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF. The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic stem cell transplant recipients. J Infect Dis 219(6):898-907, 2019. e-Pub 2019. PMID: 30295846.
- Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia EJ, Chemaly RF. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis 20(6):e12994, 2018. e-Pub 2018. PMID: 30195271.
- Azzi JM, Kyvernitakis A, Shah DP, El Haddad L, Mahajan SN, Ghantoji SS, Ariza-Heredia EJ, Chemaly RF. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection. J Antimicrob Chemother 73(11):3162-3169, 2018. e-Pub 2018. PMID: 30113677.
- Mah A, Viola GM, Ariza Heredia EJJ, Rezvani K, Kebriaei P, Bhatti MM, Han X, Shpall EJ, Mulanovich VE. Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant. Transpl Infect Dis 20(4):e12899, 2018. e-Pub 2018. PMID: 29668040.
- Ariza-Heredia EJ, Chemaly RF, Shahani LR, Jang Y, Champlin RE, Mulanovich VE. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Transpl Int 31(6):639-648, 2018. e-Pub 2018. PMID: 29464765.
- Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YT, Giordano SH, Chiao EY. Low rate of cervical cancer screening among women with hematologic malignancies after stem cell transplant. Biol Blood Marrow Transplant 24(5):1094-1098, 2018. e-Pub 2018. PMID: 29378304.
- Ariza-Heredia EJ, Granwehr BP, Viola GM, Bhatti M, Kelley JM, Kochenderfer J, Hosing C. False-positive HIV nucleic acid amplification testing during CAR T-cell therapy. Diagn Microbiol Infect Dis 88(4):305-307, 2017. e-Pub 2017. PMID: 28610774.
- El Chaer F, Shah DP, Kmeid J, Ariza-Heredia EJ, Hosing CM, Mulanovich VE, Chemaly RF. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes. Cancer 123(12):2329-2337, 2017. e-Pub 2017. PMID: 28178369.
- Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah T, Park SY, Nguyen MH, Razonable RR. Rhodococcus infection in solid organ and hematopoietic stem cell transplant recipients. Emerg Infect Dis 23(3):510-512, 2017. e-Pub 2017.
- Oliver NT, Nieto YL, Blechacz B, Anderlini P, Ariza-Heredia EJ, Torres HA. Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation. Bone Marrow Transplant 52(1):138-140, 2017. e-Pub 2017. PMID: 27427916.
- El Chaer F, Mori N, Shah D, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia EJ, Chemaly RF. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral Res 135:91-96, 2016. e-Pub 2016. PMID: 27594527.
- El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia EJ, Mulanovich VE, Gulbis AM, Shpall EJ, Chemaly RF. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Res 134:58-62, 2016. e-Pub 2016. PMID: 27582067.
- Frenzel E, Chemaly RF, Ariza-Heredia EJ, Jiang Y, Shah DP, Thomas G, Graviss L, Raad I. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control 44(9):1016-21, 2016. e-Pub 2016. PMID: 27158088.
- Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association between hepatitis C virus and head and neck cancers. J Natl Cancer Inst 108(8), 2016. e-Pub 2016. PMID: 27075854.
- Gutierrez C, Kebriaei P, Turner KA, Yemelyanova A, Ariza-Heredia EJ, Foo WC. A unique presentation of acute liver failure from herpes simplex virus hepatitis. Transpl Infect Dis 18(4):592-4, 2016. e-Pub 2016. PMID: 27222930.
- Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RF. Utility of the enzyme-linked immunospot interferon-γ-release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients. J Infect Dis 213(11):1701-7, 2016. e-Pub 2016. PMID: 26908740.
- Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF. Outcomes of influenza infections in hematopoietic cell transplant recipients: Application of an immunodeficiency scoring index. Biol Blood Marrow Transplant 22(3):542-8, 2016. e-Pub 2016. PMID: 26638804.
- Ariza-Heredia EJ, Azzi J, Shah DP, Nesher L, Ghantoji SS, Michailidis L, Marsh L, Chemaly RF. Influenza vaccination in patients with cancer: Factors associated with vaccination practices for patients and their household members. Infect Control Hosp Epidemiol 36(10):1-3, 2015. e-Pub 2015. PMID: 26132392.
- Nesher L, Rolston KV, Shah DP, Tarrand JT, Mulanovich V, Ariza-Heredia EJ, Chemaly RF. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 17(1):33-8, 2015. e-Pub 2015. PMID: 25546740.
- Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia EJ, Perego C, Nguyen DB, Nguyen K, Modarai F, Moulton-Meissner H, Noble-Wang J, Tarrand JJ, LiPuma JJ, Guh AY, MacCannell T, Raad I, Mulanovich V. Cluster and sporadic cases of herbaspirillum species infections in patients with cancer. Clin Infect Dis 60(1):48-54, 2015. e-Pub 2015. PMID: 25216687.
- Ariza-Heredia EJ, Gulbis AM, Stolar KR, Kebriaei P, Shah DP, McConn KK, Champlin RE, Chemaly RF. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice. Transpl Infect Dis 16(6):878-86, 2014. e-Pub 2014. PMID: 25405922.
- Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola GM, Ariza-Heredia EJ, Adachi JA, Chemaly RF, Marfatia R, Jiang Y, Mahale P, Kyvernitakis A, Fanale MA, Mulanovich V. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect 20(10):O672-9, 2014. e-Pub 2014. PMID: 24529214.
- Ariza-Heredia EJ, Chemaly RF. Infection control practices in patients with hematological malignancies and multi-drug resistant organisms: special considerations and challenges. Clin Lymphoma Myeloma Leuk 14 Suppl:S104-10, 2014. e-Pub 2014. PMID: 25486947.
- Chemaly RF, Ghantoji SS, Shah DP, Shah JN, El Taoum KK, Champlin RE, Nunez CA, Mulanovich V, Ariza-Heredia EJ. Respiratory syncytial virus infections in children with cancer. J Pediatr Hematol Oncol 36(6):e376-81, 2014. e-Pub 2014. PMID: 24327130.
- Ariza-Heredia EJ, Beam EN, Lesnick TG, Cosio FG, Kremers WK, Razonable RR. Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant 28(6):683-90, 2014. e-Pub 2014. PMID: 24654771.
- Shah DP, Ghantoji SS, Ariza-Heredia EJ, Shah JN, El Taoum KK, Shah PK, Nesher L, Hosing C, Rondon G, Champlin RE, Chemaly RF. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood 123(21):3263-8, 2014. e-Pub 2014. PMID: 24700783.
- Mahajan SN, Ariza-Heredia EJ, Rolston KV, Graviss LS, Feig BW, Aloia TA, Chemaly RF. Perioperative antimicrobial prophylaxis for intra-abdominal surgery in patients with cancer: a retrospective study comparing ertapenem and non-ertapenem antibiotics. Ann Surg Oncol 21(2):513-9, 2014. e-Pub 2014. PMID: 24114052.
- Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant 18:195-204, 2013. e-Pub 2013. PMID: 23792521.
- Shah DP, Ghantoji SS, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF. Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res 2(4):203-18, 2012. e-Pub 2012. PMID: 23226621.
- Ariza-Heredia EJ, Patel R, Blumberg EA, Walker RC, Lewis R, Evans J, Sankar A, Willliams MD, Rogers J, Milano C, Razonable RR. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis 14(3):229-36, 2012. e-Pub 2012. PMID: 22624726.
- Ariza-Heredia EJ, Fishman JE, Cleary T, Smith L, Razonable RR, Abbo L. Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience. Transpl Infect Dis 14(1):64-71, 2012. e-Pub 2012. PMID: 22093238.
- Ariza-Heredia EJ, Razonable RR. Incidental hepatic schistosomiasis in a liver transplant recipient. Transpl Infect Dis 14(1):75-8, 2012. e-Pub 2012. PMID: 21504529.
- Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis 71(4):421-7, 2011. e-Pub 2011. PMID: 21945390.
- Ariza Heredia EJ, Espinoza L, Abbo L. Salmonella bacteremia and ovarian abscess in an HIV-infected woman. Inf Dis in Clinical Practice 19(6):442-444, 2011. e-Pub 2011.
- Abbo L, Sinkowitz-Cochran R, Smith L, Ariza-Heredia EJ, Gómez-Marín O, Srinivasan A, Hooton TM. Faculty and resident physicians' attitudes, perceptions, and knowledge about antimicrobial use and resistance. Infect Control Hosp Epidemiol 32(7):714-8, 2011. e-Pub 2011. PMID: 21666405.
- Munoz-Price LS, Ariza-Heredia E, Adams S, Olivier M, Francois L, Socarras M, Coro G, Adedokun A, Pappas T, Tamayo M, McDade R, Dezfulian C. Use of UV powder for surveillance to improve environmental cleaning. Infect Control Hosp Epidemiol 32(3):283-5, 2011. e-Pub 2011. PMID: 21460514.
- Abbo L, Quartin A, Morris MI, Saigal G, Ariza-Heredia E, Mariani P, Rodriguez O, Muñoz-Price LS, Ferrada M, Ramee E, Rosas MI, Gonzalez IA, Fishman J. Pulmonary imaging of pandemic influenza H1N1 infection: relationship between clinical presentation and disease burden on chest radiography and CT. Br J Radiol 83(992):645-51, 2010. e-Pub 2010. PMID: 20551254.
Invited Articles
- Ariza-Heredia EJ, Chemaly RF. Practical Review of Immunizations in Adult Patients with Cancer. Hum Vaccin Immunother 11(11):2606-14, 2015. e-Pub 2015. PMID: 26110220.
- Abbo LM, Ariza-Heredia EJ. Antimicrobial Stewardship in Immunocompromised Hosts. Infect Dis Clin North Am 28(2):263-79, 2014. e-Pub 2014. PMID: 24857392.
- Ariza-Heredia EJ, Nesher L, Chemaly RF. Cytomegalovirus Diseases after Hematopoietic Stem Cell Transplantation: A Mini-Review. Cancer Lett 342(1):1-8, 2014. e-Pub 2014. PMID: 24041869.
- Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation 92(8):837-44, 2011. e-Pub 2011. PMID: 21946171.
Review Articles
- Shafat, T, Ariza Heredia, EJ, Daher, M, Chemaly, RF. How we diagnose and manage refractory and resistant herpes simplex virus mucocutaneous infection after haematopoietic cell transplantation. Clinical Microbiology and Infection 31(5):761-772, 2025. e-Pub 2025. PMID: 39900291.
- Chiu, CY, John, TM, Matsuo, T, Wurster, ST, Hicklen, RS, Khattak, RR, Ariza Heredia EJ, Bose, P, Kontoyiannis, DP. Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib. Journal of Fungi 10(4), 2024. e-Pub 2024. PMID: 38667935.
- Wilson Dib R, Ariza-Heredia EJ, Spallone A, Chemaly RF. Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention. Open Forum Infect Dis 10(4):ofad166, 2023. e-Pub 2023. PMID: 37065990.
- Ariza-Heredia EJ, Chemaly RF. Update on infection control practices in cancer hospitals. CA Cancer J Clin 68(5):340-355, 2018. e-Pub 2018. PMID: 29985544.
- Shahani L, Ariza-Heredia EJ, Chemaly RF. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther 15(4):1-15, 2017. e-Pub 2017. PMID: 28067078.
- Ariza-Heredia EJ, Kontoyiannis DP. Our recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers. Mycoses 57(6):336-41, 2014. e-Pub 2014. PMID: 24446760.
Professional Educational Materials
- Tutt B. Improving Rates of Vaccination after Hematopoietic Stem Cell Transplant. The University of Texas MD Anderson Cancer Center, 2016.
- Stolar K, Gulbis A, McConn K, Ariza-Heredia EJ. Vaccination after Stem Cell Transplant. Patients Questions and Answers, 2015.
Abstracts
- Ariza-Heredia EJ, Jackson J, Gould S, Tarvin-Walker T, Jawe N, Vondenstein M, Melton M, Hoang T, Abraham J, Villanueva V, Thomas J, Alvarado I, Trask R, Delosreyes C, Benavides D, Delosreyes C, Balason A, Jurisprudencia C, Espinosa A. Improving Influenza Vaccination Assessment at the General Internal Medicine Clinics, 2026. e-Pub 2026.
- Trager S, Chemaly RF, Ahmed S, Lu H, Nze C, Ariza-Heredia EJ, Khawaja F. Humoral Responses to Two versus One Dose of Pneumococcal Conjugate Vaccine 20 (PCV20) in Lymphoma Survivors at 3 Months Follow Up, 2025. e-Pub 2025.
- Ohashi Y, Chemaly RF, Khawaja F, Daher M, Spallone A, Shafat T, Ariza-Heredia EJ, Handley G. Factors Associated with Human Herpesvirus 6 DNAemia Among Allogeneic Hematopoietic Cell Transplant Recipients in the Modern Era, 2025. e-Pub 2025.
- Daher M, Makhoul J, Lopez V, Shafat T, Spallone A, Shigel TL, Sassine J, Febres A, Morado-Aramburo O, Ariza-Heredia EJ, Khawaja F, Chemaly RF. Risk Factors and Outcomes of Resistant CMV Infections in Hematopoietic Cell Transplant Recipients: a 7-Year Review, 2025. e-Pub 2025.
- Jackson J, Vondenstein M, Gould S, Melton M, Espinoza A, Abraham J, Alvarado I, Thomas J, Trask R, Hoang T, Kaufman L, Ariza-Heredia EJ. Improving Pneumococcal Vaccination Assessment and Rates One Step at a Time in a Cancer Center, 2025. e-Pub 2025.
- Gaulin C, Chemaly RF, Jiang Y, Ramdial J, Ahmed S, Roldon G, Ariza-Heredia EJ, Spallone A, Iyer S, Kebriaei P, Srour S, Shpall E, Nastoupil L, Khawaja F. Incidence and Risk Factors for Fungal Infection after CD19-targeted Chimeric Antigen Receptor T Cell Therapy for Non-Hodgkin Lymphoma, 2024. e-Pub 2024.
- Angelidakis G, Shafat T, Yaghi L, Khawaja F, Pignataro Oshiro F, Kirsch J, Ariza-Heredia EJ, Batista M, Gollob K, Duerkop B, Chemaly R, Spallone A. Outcomes of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients with Leukemia: A Prospective Study, 2024. e-Pub 2024.
- Makhoul J, Jetty S, Khawaja F, Patel K, Lee H, Horowitz S, Spallone A, Ariza-Heredia EJ, Chemaly R. Cytomegalovirus Infections in Patients with Relapsed/Refractory Multiple Myeloma on Novel T-Cell Redirecting Therapy, 2024. e-Pub 2024.
- Shafat T, Khawaja F, Angelidakis G, Yaghi L, Spallone A, Ariza-Heredia EJ, Chemaly R. Prognostic Value of the Immunodeficiency Scoring Index for Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients, 2024. e-Pub 2024.
- Daher M, Khawaja F, Spallone A, Shigle TL, Ariza-Heredia EJ, Bhatti M, Chemaly R. Real-World Experience with Maribavir for the Treatment of Cytomegalovirus Infection in Patients with Hematologic Malignancies, 2024. e-Pub 2024.
- Jetty S, Makhoul J, Khawaja F, Lee H, Patel K, Horowitz S, Ariza-Heredia EJ, Spallone A, Chemaly R. Infectious Complications in Patients with Relapsed/Refractory Multiple Myeloma Undergoing Novel Bispecific Antibody Therapy: A Myeloma-Infectious Disease Database Initiative, 2024. e-Pub 2024.
- Shafat T, De la Rosa Martinez D, Khawaja F, Jian Y, Spallone A, Batista M, Ariza-Heredia EJ, Vilar-Compte D, Chemaly R. Risk Factors for Severe Influenza and Respiratory Syncytial Virus Infections in Patients with Lymphoma or Multiple Myeloma - A Seven-Year Retrospective Cohort Study, 2024. e-Pub 2024.
- Shafat T, LaCombe R, Yaghi L, Angelidakis G, Spallone A, Ariza-Heredia EJ, Hanna G, Ulloa I, Sinha R, Morris P, Howard-Shipley K, Kleiboeker S, Khawaja F, Chemaly RF. Evaluation of a Meta-Virus Signature as a Diagnostic Tool to Predict the Severity of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients, 2024. e-Pub 2024.
- Jackson J, Tereffe W, Espinosa A, Tealer K, Abrahams J, Thomas J, Kaufman L, Alvarado I, Trask R, Vondenstein M, Ariza-Heredia EJ. Improving Influenza Vaccination Rates Among Cancer Patients, 2024. e-Pub 2024.
- Papanicolau G, Dadwal S, Ariza-Heredia EJ, Haber B, Broyde N, Gilbert C, Badshah C. A Prospective Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity (CMV-CMI) in a Multicenter Phase 3 Randomised Placebo-Controlled Trial of Letermovir Prophylaxis in CMV-Seropositive Recipients (R+) of an Allogeneic Haematopoietic Cell Transplant (HCT), 2024. e-Pub 2024.
- Ariza-Heredia EJ, Jackson J, Tealer K, Kauffman L, Vondenstain M, Tereffe W, Espinosa A, Abraham J, Thomas J, Alvarado I, Trask R. Improving Vaccination Rates Among Cancer Patients, 2024. e-Pub 2024.
- Febres-Aldana AJ, Khawaja F, Spallone A, Srinivasan K, Shigle TL, Aramburo OM, Rondon G, Ramdial J, Shpall E, Ariza-Heredia EJ, Chemaly RF, Sassine J. Duration of Letermovir Primary Prophylaxis in Hematopoietic Cell Transplant Recipients at High Risk for Cytomegalovirus Infections and Impact on Outcomes, 2023. e-Pub 2023.
- Angelidakis G, Chemaly RF, Kebriaei P, Ajami NJ, Bhatti M, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Wargo J, Jenq R, Ariza-Heredia EJ. Assessment of Retained Immunity and Antibody Response to Vaccine Preventable Infections in Patients Undergoing Immune Effector Cell Therapy, 2023. e-Pub 2023.
- Angeldakis G, Khawaja F, Rishab P, Ahmed S, Ramdial J, Nieto Y, Rondon G, Ariza-Heredia EJ, Spallone A, Iyer S, Chemaly RF. The Impact of Human Herpes Virus 6 Infection within The First Year Following Chimeric Antigen Receptor T-Cell Therapy in a Comprehensive Cancer Center, 2023. e-Pub 2023.
- Wilson, R, Khawaja F, Rishab P, Ahmed S, Ramdial J, Nieto Y, Rondon G, Ariza-Heredia EJ, Spallone A, Iyer S, Chemaly RF. Respiratory Viral Infections in CART Recipients at a Comprehensive Cancer Center, 2023. e-Pub 2023.
- Srinivasan K, Spallone A, Khawaja F, Sassine J, Morado Aramburo O, Febres-Aldana AJ, Rondon G, Ramdial J, Shpall E, Ariza-Heredia EJ, Chemaly RF. The Impact of HHV-6 DNAemia on Hematopoietic Cell Transplant (HCT) Recipients at High Risk for CMV Reactivation in the Era of Letermovir, 2022. e-Pub 2022.
- Daher M, Khawaja, Angelidakis G, Rondon G, Spallone A, Ramdial J, Ariza-Heredia EJ, Shpall E, Chemaly RF. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients, 2022. e-Pub 2022.
- Morado Aramburo O, Spallone A, Khawaja F, Sassine J, Srinivasan K, Febres-Aldana AJ, Shigle TL, Rondon G, Ramdial J, Shpall E, Ariza-Heredia EJ, Chemaly RF. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir, 2022. e-Pub 2022.
- Febres-Aldana AJ, Srinivasan K, Morado Aramburo O, Khawaja F, Spallone A, Sassine J, Shigle TL, Rondon G, Ramdial J, Shpall E, Ariza-Heredia EJ, Chemaly RF. Long Term Hematopoietic Cell Transplant Outcomes in Patients at High Risk for Cytomegalovirus Infections in the Era of Letermovir, 2022. e-Pub 2022.
- Khawaja F, Sadaka C, Angelidakis G, Trager S, Spallone A, Ariza-Heredia EJ, Shpall E, Chemaly RF. The Use of Cytomegalovirus (CMV) T Cell Immunity Panel to Assess the Risk of CMV Infection in Recipients of Cellular Therapy with Low Level CMV Viremia, 2022. e-Pub 2022.
- Angelidakis G, Chemaly RF, Kebriaei P, Ajami NJ, Bhatti M, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Wargo J, Jenq R, Ariza-Heredia EJ. Evaluation of Antibody Titers and Antibody Response to Immunizations in Survivors of Immune Effector Cell Therapy, 2022. e-Pub 2022.
- Spallone A, Khawaja F, Ariza-Heredia EJ, Papanicolaou G, Boeckh M, Dadwal S, Abidi M, Camargo JF, El Boghdadly Z, Shahid Z, Chemaly RF. Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic, 2022. e-Pub 2022.
- Spallone A, Khawaja F, Ariza-Heredia EJ, Papanicolaou G, Boeckh M, Dadwal S, Abidi M, Camargo JF, El Boghdadly Z, Shahid Z, Chemaly RF. Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic, 2022. e-Pub 2022.
- Spallone A, Srinivasan K, Sassine J, Shigle TL, Handy VW, Ramdial J, Khawaja F, Ariza-Heredia EJ, Chemaly RF. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis, 2021. e-Pub 2021.
- Angelidakis G, Chemaly RF, Kebriaei P, Ajami NJ, Bhatti M, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Wargo J, Jenq R, Ariza-Heredia EJ. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies, 2021. e-Pub 2021.
- Khawaja F, Sadaka C, Trager S, Ariza-Heredia EJ, Spallone A, Altrich M, Cheamly RF. The Use of a Commercially Available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia, 2021. e-Pub 2021.
- Sassine J, Khawaja F, Shank BR, Lovell A, Lee J, DiPippo A, Rausch C, Spallone A, Ariza-Heredia EJ, Chemaly RF. Clinically Significant CMV Infections in Patients with Lymphoma or Multiple Myeloma, 2021. e-Pub 2021.
- Sassine J, Khawaja F, Handy V, Shigle TL, Foolad F, Aitken S, Ariza-Heredia EJ, Chemaly RF. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era, 2020. e-Pub 2020.
- Khawaja F, Mullane K, Ariza-Heredia EJ, El Haddad L, Tang Y, Raval AD, Chemaly RF. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients: A Multicenter Analysis, 2020. e-Pub 2020.
- De la Rosa Martinez D, Vilar-Compte D, Batista M, Khawaja F, Ariza-Heredia EJ, Chemaly R. Respiratory Viral Infections in Patients with Lymphoma and Multiple Myeloma: Risk Factors Associated with Progression to Lower Respiratory Tract Infection and Mortality, 2019. e-Pub 2019.
- Strati P, Adkins S, Nastoupil L, Westin J, Hagemeister F, Fowler N, Lee H, Fayad L, Samaniego S, Varma A, Arafat S, Johncy S, Kebriaei P, Mulanovich V, Ariza-Heredia EJ, Neelapu S. Hematopoietic Recovery and Immune Reconstitution after Axi-cell CAR T-Cell Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma, 2019. e-Pub 2019.
- Ariza-Heredia EJ, Sacca L, Batista M, El Haddad L, Khawaja F, Viola GM, Hachem J. Outcomes of Influenza Infection in Vaccinated and Non-Vaccinated Patients with Cancer, 2019. e-Pub 2019.
- Viola GM, Rolston KV, Butler C, Selber J, Reece G, Clemens M, Villa M, Ariza-Heredia EJ, Raad I, Baumann D. Are Current Perioperative Antimicrobial Regimens Adequate for the Prevention of Breast Implant-Based Reconstructive Surgeries?, 2019. e-Pub 2019.
- Aldoss I, Baden L, Ariza-Heredia EJ, La Rosa C, Longmate J, Slape C, Duarte L, Dagis A, Farol L, Nademanee A, Al Malki M, Issa N, Pandit A, Haddad Arbona E, Zaia J, Forman S, Nakamura R, Diamond D. Multi-Antigen Vaccine (TRIPLEX) Based on Attenuated Poxvirus Prevents Cytomegalovirus Viremia in a Multi-Center Placebo Controlled, Double Blinded, Randomized Phase 2 Clinical Trials in Allogeneic HCT Recipients, 2019. e-Pub 2019.
- Sacca L, Chemaly R, Batista M, Jiang Y, El Haddad L, Ariza-Heredia EJ. Impact of Influenza Vaccination on Outcomes of Influenza Infections in Immunocompromised Patients, 2019. e-Pub 2019.
- Batista M, Artau A, Aitken S, Khawaja F, El Chaer F, El Haddad L, Mulanovich V, Ariza-Heredia EJ, Chemaly R. Clinical Validation of the Definitions of Resistant and Refractory Cytomegalovirus (CMV) Infection and Disease in Hematopoietic Cell Transplant (HCT) Recipients, 2019. e-Pub 2019.
- Khawaja F, Lynn T, Ghantoji S, Batista M, Ariza-Heredia EJ, Chemaly RF. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopoietic Cell Transplant (HCT) Recipients, 2018. e-Pub 2018.
- Kulkarni P, Kmeid J, Batista M, Ariza-Heredia EJ, Graviss E, Mulanovich V, Chemaly RF. Comparison of Interferon-gamma Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients, 2018. e-Pub 2018.
- Artau A, Aitken S, Batista M, El Chare F, Prayag A, El Haddad M, Mulanovich V, Ariza-Heredia EJ, Chemaly R. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant, 2018. e-Pub 2018.
- Foolad F, Aitken S, Shigle T, Prayag A, Ghanthoji S, Shah D, Ariza-Heredia EJ, Chemaly R. Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant Recipients, 2017. e-Pub 2017.
- Ariza-Heredia EJ, Shah DP, Winston DJ, Rowley SD, Mullane KM, Chandrasekar P, Hari P, Avery R, Peggs KS, Kumar D, Nath R, Ljungman PT, Mossad S, Dadwal SS, Cruikshank W, Chemaly RF. A Prospective Observational Study to Evaluate a Cytomegalovirus (CMV) Specific Enzyme-Linked Immunospot (Elispot) Assay in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients: The REACT Study, 2017. e-Pub 2017.
- Ariza-Heredia EJ, Hwang JP, Viola GM, Chemaly RF, Jiang Y, Ramondetta L, Guo M, Ahmed S. Time to Re-Evaluate Recommendations for Prevention of Human Papillomavirus (HPV) Infections after Stem Cell Transplantation (HSCT), 2017. e-Pub 2017.
- Ariza-Heredia EJ, Hwang JP, Guo M, Chemaly RF, Ahmed S. Risk Factors for HPV Positivity in Patients who received Allogeneic Stem Cell Transplant, 2017. e-Pub 2017.
- Ariza-Heredia EJ, Shah DP, El Chaer F, Chemaly RF. The Ability of CMV-Specific Elispot Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients, 2017. e-Pub 2017.
- Ariza-Heredia EJ, Shah DP, Winston DJ, Rowley SD, Mullane KM, Chandrasekar P, Hari P, Avery R, Peggs KS, Kumar D, Nath R, Ljungman PT, Mossad S, Dadwal SS, Cruikshank W, Chemaly RF. A Prospective Observational Study to Evaluate a Cytomegalovirus (CMV)-Specific Enzyme-Linked Immunospot (Elispot) Assay in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients: The REACT Study, 2017. e-Pub 2017.
- Ariza-Heredia EJ, Shah DP, Winston DJ, Rowley SD, Mullane KM, Chandrasekar P, Hari P, Avery R, Peggs KS, Kumar D, Nath R, Ljungman PT, Mossad S, Dadwal SS, Cruikshank W, Chemaly RF. The Impact of Pre- and Week 4 Post-Transplant CMV-Specific Elispot Assay on CMV Reactivation and Survival in CMV-Seropositive Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients, 2017. e-Pub 2017.
- Ariza-Heredia EJ, Shah D, El Chaer F, Mullane K, Rowley S, Chandrasekar P, Winston D, Hari P, Gillis H, Nath R, Kumar D, Mossad S, Ljungman P, Chemaly R. A Prospective Observational Study to Evaluate a Cytomegalovirus (CMV) specific T-SPOT® Assay in Hematopoietic Stem Cell Transplant Recipients: The REACT Study Interim Data Review, 2016. e-Pub 2016.
- Taremi M, Shah D, El-Haddad D, El Chaer F, El Haddad L, Prayag A, Rondon G, Hosing C, Ariza-Heredia EJ, Chemaly R. Rhinovirus Infections (RhVI) in 233 Hematopoietic Cell Transplant (HCT) Recipients: A Single Center Experience, 2016. e-Pub 2016.
- Shah D, Ariza-Heredia EJ, El Chaer F, El Haddad L, El-Haddad E, Prayag P, Nesher L, Rezvani K, Shpall E, Chemaly R. The ability of CMV–specific ELISPOT assay to predict outcome of low level CMV reactivation in hematopoietic cell transplant recipients, 2016. e-Pub 2016.
- Larson AJ, MacKenney K, Jimenez C, Ariza-Heredia EJ, Knox A, Murphy V, Balachandran D, Ost DE, Immanivong N, Shannon VR, Grosu HB, Eapen GA, Faiz SA, Bashoura L. Pneumococcal Vaccination in a Cancer Center, 2016. e-Pub 2016.
- Vakil E, Faiz S, Shah DP, Kmeid J, El Chaer F, Bashoura L, Ariza-Heredia EJ, Chemaly RF. Evaluation of Bronchoscopy and Radiographic Imaging in Respiratory Syncytial Virus Infection in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients, 2016. e-Pub 2016.
- Ariza-Heredia EJ, Chemaly RF, Jiang Y, Mulanovich VE. High Morbidity of Acyclovir Resistant Herpes Simplex Virus Infections among Allogeneic Stem Cell Transplant Recipients, 2016. e-Pub 2016.
- Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association between Hepatitis C Virus and Head and Neck Cancers, 2016. e-Pub 2016.
- Ariza-Heredia EJ, Viola GM, Blue Schaneville K, Gulbis A, Chemaly R, Rolston K, Stolar K. Evaluation of Long-Term Immunity to Varicella, Measles, Mumps, Rubella in Hematopoietic Stem Cell Transplant Survivors, 2016. e-Pub 2016.
- Viola GM, Ariza-Heredia EJ, Mulanovich VE. Disseminated Strongyloidiasis and Hematopoietic Stem Cell Transplantation, 2016. e-Pub 2016.
- Kmeid J, Shah DP, El Chaer F, Ariza-Heredia EJ, Graviss E, Mulanovich VE, Chemaly RF. The Utility of Interferon-Gamma Release Assays for the Diagnosis of Mycobacterium Tuberculosis in Hematopoietic Cell Transplant Recipients, 2016. e-Pub 2016.
- El Chaer F, Shah DP, Kmeid J, Ariza-Heredia EJ, Hosing C, Chemaly RF. Human Metapneumovirus Infections in 83 Hematopoetic Cell Tranplant Recipients, 2016. e-Pub 2016.
- Shah DP, Ghantoji SS, Azzi J, Avadhanula V, Kmeid J, El Chaer F, Ariza-Heredia EJ, Shah N, Mulanovich VE, Hosing C, Piedra P, Chemaly RF. An Open Label, Block Randomized, Ribavirin Efficacy Trial for Management of RSV Infections in Hematopoietic Cell Transplant Recipients: Clinical and Economic Implications, 2016. e-Pub 2016.
- Ariza-Heredia EJ, Chemaly RF, Jiang Y, Mulanovich VE. Acyclovir Resistant Herpes Simplex Virus in Stem Cell Transplant Recipients, 2016. e-Pub 2016.
- Kmeid J, Vanichanan J, Shah D, El Chaer F, Azzi J, Ariza-Heredia EJ, Mulanovich V, Chemaly RF. Clinical Outcomes Following Influenza Including 2014/H3N2 Infection in Hematopoietic Cell Transplant (HCT) Recipients, 2015. e-Pub 2015.
- El Chaer F, Shah D, Kmeid J, Ariza-Heredia EJ, Hosing C, Chemaly RF. Human Metapneumovirus (hMPV) infections in 135 Cancer Patients, 2015. e-Pub 2015.
- Kmeid J, Shah DP, El Chaer F, Ariza-Heredia EJ, Graviss E, Mulanovich V, Chemaly RF. The Utility of Interferon-Gamma Release Assays (IGRAs) for the Diagnosis of Mycobacterium Tuberculosis (Mtb) in Cancer Patients, 2015. e-Pub 2015.
- Shah DP, Nesher L, Ariza-Heredia EJ, Azzi JM, Siddiqui H, Ghantoji SS, Marsh L, El Chaer F, Makedonas G, Rezvani K, Shpall E, Chemaly RF. Dynamics of CMV-specific T cell Recovery in Allogeneic Hematopoietic Cell Transplant Recipients: Implications for Clinical Outcomes, 2015. e-Pub 2015.
- Shah DP, Ghantoji S, Azzi JM, Avadhanula V, El Chaer F, Ariza-Heredia EJ, Mulanovich V, Piedra P, Chemaly RF. Cost-effectiveness of Immunodeficiency Scoring Index (ISI-RSV) and Oral Ribavirin for Management of Respiratory Syncytial Virus (RSV) Infections in Hematopoietic Cell Transplant (HCT) Recipients, 2015. e-Pub 2015.
- Shah DP, Avadhanula V, Piedra P, Ghantoji S, Aziz J, Ariza-Heredia EJ, Chemaly R. Viral Genomic Load Kinetics in Hematopoietic Cell Transplant (HCT) Recipients with Respiratory Syncytial Virus (RSV) Infections: A Single Center Cluster-Randomized, Ribavarin Efficacy Trial, 2015. e-Pub 2015.
- Shah D, Avadhanula V, Piedra P, Ghantoji S, Azzi J, Ariza-Heredia EJ, Nesher L, Marsh L, Delano E, Chemaly R. Viral Genomic Load (VGL) Kinetics in Hematopoietic Stem Cell Transplant (HCT) Recipients with RSV Infections, 2014. e-Pub 2014.
- Azzi J, Bashoura L, Shah D, Alousi A, Ghantoji S, Nesher L, Rondon G, Ariza-Heredia EJ, Chemaly R. The Long-Term Impact of Respiratory Viral Infections (RVI) on Pulmonary Function in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients, 2014. e-Pub 2014.
- Nesher L, Ariza-Heredia EJ, Shah D, Azzi J, Ghantoji S, Michadilis L, Rezvani K, Shpall E, Chemaly R. The Impact of IL-28b Polymorphism in Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients on Interferon (INF Gamma) Production and CMV Reactivation, 2014. e-Pub 2014.
- Nesher L, Ariza-Heredia EJ, Shah D, Azzi J, Ghantoji S, Michadilis L, Rezvani K, Shpall E, Chemaly R. Immune Monitoring with the T-SPOT CMV Assay of Allogeneic Hematopoietic Stem Cell Transplant (allo-HCT) Recipients: A Proof of Concept in the Clinical Setting, 2014. e-Pub 2014.
- Viola GM, Adachi JA, Ariza-Heredia EJ, Yang W, Villa MT, Butler CE, Kronowitz S, Clemens MW, Selber JC, Baumann DP. Breast Tissue Expander-Related Infections: A Standardized Multidisciplinary Approach to Salvaging the Implant, 2014. e-Pub 2014.
- Torres HA, Ralllapalli V, Saxena A, Granwehr B, Viola G, Ariza-Heredia EJ, Adachi J, Chemaly R, Marfatia R, Jiang Y, Mahale P, Kyvernitakis A, Fanale M, Mulanovich V. Efficacy and Safety of Antiretrovirals in HIV-infected Patients with Cancer, 2014. e-Pub 2014.
- Ariza-Heredia EJ, Gulbis A, Kebriae P, Stolar K, McConn K, Mulanovich V, Viola G, Chemaly RF. Compliance with Post-Haematopoietic Stem Cell Transplantation Vaccination Consensus Guidelines, 2014. e-Pub 2014.
- Nesher L, Chemaly RF, Rezvani K, Shpall E, Shah D, Ariza-Heredia EJ. Immune Monitoring of Allogeneic Hematopoietic Stem Cell Transplantat (allo-HSCT) Recipients at Risk for Cytomegalovirus (CMV) Reactivation: A Prospective Observational Study, 2014. e-Pub 2014.
- Doan V, Yeh J, Gulbis A, Ariza-Heredia EJ, Ahmed S. Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation, 2014. e-Pub 2014.
- Vanichanan J, Nieto Y, Mulanovich V, Ariza-Heredia EJ, Roldon G, Shah D, Chemaly R. Central Nervous System Complications After Hematopoietic Stem Cell Transplantation, 2013. e-Pub 2013.
- Nesher L, Sha D, Ariza-Heredia EJ, Rolston K, Chemaly R. Pseudomonas aeruginosa Predicts Infection in Recipients of Allogeneic Stem Cell Transplantation, 2013. e-Pub 2013.
- Ariza-Heredia EJ, Gulbis A, Stolar K, Kebriae P, McConn K, Champlin R, Mulanovich V, Chemaly R. Vaccination Guidelines after Stem Cell Transplantation: Practitioner's Knowledge and Attitudes, and the Gap between Guidelines and Clinical Practice, 2013. e-Pub 2013.
- Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola G, Ariza-Heredia EJ, Chemaly RF, Jiang Y, Marfatia R, Shelburne S, Mulanovich V. Efficacy and Safety of Antiretrovirals in HIV-Infected Patients with Cancer, 2013. e-Pub 2013.
- Shah D, Alousi A, Bashoura L, Ghantoji S, Rondon G, Mulanovich V, Ariza Heredia EJ, Chemaly R. Validating an Immunodeficiency Scoring Index (ISI) to Predict Pneumonia and Mortality in Allogeneic Stem Cell Transplant (allo-HCT) recipients with RSV, Influenza, and Parainfluenza Virus Infections, 2013. e-Pub 2013.
- Vanichanan J, Vilar-Compte D, Shah D, Volkow P, Cornejo-Juarez P, Perez-Jimenez C, Saad M, Mulanovich V, Ariza-Heredia EJ, Chemaly R. A Multicenter Study of Pandemic H1N1 Influenza (pH1N1) Infections in Patients with Hematologic Malignancies (HM) and Hematopoietic Cell Transplant (HCT) Recipients from 3 Countries, 2013. e-Pub 2013.
- Mahajan SN, Ghantoji SS, Shah DJ, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF. Impact of RSV Infection in Patients with Lymphoma or Multiple Myeloma (MM): A Single Center Study, 2012. e-Pub 2012.
- Shah D, Alousi A, Bashoura L, Shah P, Mahajan S, Mulanovich V, Ariza-Heredia EJ, Chemaly R. Bronchiolitis Obliterans following Respiratory Viral Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients, 2012. e-Pub 2012.
- Ariza Heredia EJ, Kazimirko E, Lesnick T, Kremers W, Cosio F, Razonable R. Trimethoprim-Sulfamethoxazole (TMP-SMZ) Prophylaxis for Pneumocystis jirovecii (PCP) Reduces the Risk of Urinary Tract Infection and its Recurrence in Kidney Transplant Recipients, 2011. e-Pub 2011.
- Ariza Heredia EJ, Kremers W, Lesnick T, Cosio F, Razonable RR. Urinary Tract Infection in Solitary Kidney Transplant Recipients: An Institutional Cohort Study of Risk Factors and Allograft Outcomes, 2011. e-Pub 2011.
- Ariza-Heredia EJ, Fishman J, Cleary T, Smith L, Razonable RR, Abbo L. Clinical and Radiological Findings of Respiratory Syncytial Virus in Solid Organ Transplant Recipients, 2011. e-Pub 2011.
- Ariza-Heredia EJ, Dezfulian C, Morris MM, Munoz-Price S. Retrospective Review of Gram-Negative Bacteremia in Solid Organ Transplant Population, 2010. e-Pub 2010.
- Munoz-Price S, Adams S, Ariza-Heredia EJ. Improvement in Operating Room Environmental Cleaning Using UV Powder Surveillances, 2010. e-Pub 2010.
- Munoz-Price S, Dezfulian C, Ariza-Heredia EJ, Adams S, Olivier M, Francois L, Socarras M, Coro G, Adedokun A, Pappas T, Tamayo M. Brief UV Powder Surveillance and Reporting Results in Sustained Improvements in ICU Environmental Cleaning, 2010. e-Pub 2010.
- Ariza-Heredia EJ, Garisto J, Carrillo R. Correlation of Fever and Elevated Leukocyte Count with Chest CT Findings of Septic Pulmonary Emboli in Cardiac Device Related Infections, 2009. e-Pub 2009.
Book Chapters
- Malek, A, Ariza Heredia EJ. Infection Control, Prophylaxis, and Vaccinations in Hematopoietic Cell Transplantation Recipients. In: Manual of Stem Cell Transplantation and Cellular Therapies for Hematologic Malignancies. Elsevier, 413-428, 2023.
- Ariza-Heredia EJ, El Chaer F, Chemaly RF. Antiviral Treatment and Prophylaxis in Immunocompromised Host. In: Management of Infections in the Immunocompromised Host. Springer, 317-337, 2018.
- Ariza-Heredia EJ, Chemaly RF. Influenza and Parainfluenza Infections after Hematopoietic Stem Cell and Solid Organ Transplantation. In: Transplant Infections. 4th. Springer, 2016.
- Baracco G, Ariza-Heredia EJ. Neisseria meningitidis. In: Infection Control and Epidemiology. 3rd, 75:1-5, 2009.
- Ariza-Heredia EJ, Viola GM. Antimicrobial Management of Neutropenic Fever in Hematopoietic Stem Cell Transplant Recipients. In: The AST Handbook of Transplant Infections. Wiley.
Letters to the Editor
- El Haddad L, Ariza-Heredia EJ, Chemaly RF. Response to Giménez et al. J Infect Dis 219: 1512-1513, 2019.
Patient Reviews
CV information above last modified March 06, 2026